|
|
|
Cogentin advertisement, 1958 Mental Hospitals, Vol. 9, No. 9, p. 2. to control tranquilizer-induced Parkinson-like side effects COGENTIN® methanesulfonate (benztropine methanesulfonate) 'Cogentin' is effective in providing relief for many patients who develop tremor, restlessness, feelings of tension and other Parkinson-like symptoms during tranquilizer treatment of mental disorders. Dosage and administration: Recommended dosage is one-half to one tablet two or three times a day. If higher doses are required, the patient should be closely observed and dosage adjusted as indicated. When 'Cogentin' is used to offset the distressing Parkinson-like side effects caused by tranquilizing drugs, adequate therapy with these drugs may usually be continued. Rarely, a decrease in dosage may be necessary. Supplied: As 2 mg. quarterscored tablets in bottles of 100 and 1000. Cogentin is a trade-mark of Merck & Co., Inc. Merck Sharp & Dohme Division of Merck & Co., Inc., Philadelphia 1, PA. |